- Home
- TVTX vs LMND Comparison
TVTX vs LMND Comparison
Compare TVTX & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TVTX | LMND |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.4B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TVTX | LMND |
|---|---|---|
| Price | $62.14 | $52.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $40.62 | ★ $70.86 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.89 | 21.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $737,900,000.00 |
| Revenue This Year | $44.76 | $65.20 |
| Revenue Next Year | $35.51 | $33.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.15 |
| 52 Week Low | $17.05 | $46.16 |
| 52 Week High | $66.24 | $99.90 |
Technical Indicators
Market Signals| Indicator | TVTX | LMND |
|---|---|---|
| Relative Strength Index (RSI) | 62.67 | 41.16 |
| Support Level | $53.76 | $50.33 |
| Resistance Level | $66.24 | $59.65 |
| Average True Range (ATR) | 2.59 | 2.72 |
| MACD | 0.27 | -0.04 |
| Stochastic Oscillator | 67.32 | 37.73 |
Price Performance
Historical ComparisonAbout TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.